News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Monahan Joseph
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
4
| Monahan Joseph (Chief Scientific Officer) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 6,000 shares
@ $7.3158, valued at
$43.9k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/03/2023 |
4
| Monahan Joseph (Chief Scientific Officer) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 14,800 shares
@ $12.3665, valued at
$183k
Sold 16,037 shares
@ $12.6342, valued at
$202.6k
Exercised 13,750 restricted stock units
@ $0
Exercised 50,000 restricted stock units
@ $0
Exercised 10,925 restricted stock units
@ $0
Exercised 12,500 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Monahan Joseph (Chief Scientific Officer) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $15.8823, valued at
$79.4k
|
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| Monahan Joseph (Chief Scientific Officer) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 30,000 shares
@ $16.2766, valued at
$488.3k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|